What are the phases of abdominal contrast‑enhanced computed tomography (CECT) and what is the clinical relevance of each phase?

Phases of Abdominal CECT and Clinical Relevance

Standard Protocol Overview

For comprehensive abdominal CECT evaluation, a multiphasic protocol including noncontrast, late arterial (35 seconds), portal venous (60-70 seconds), and delayed (90+ seconds) phases should be employed, with specific phase combinations tailored to the clinical indication. 1

The selection of phases directly impacts diagnostic accuracy and should be guided by the suspected pathology rather than routine acquisition of all phases.

Individual Phase Timing and Clinical Applications

Noncontrast Phase

• Timing: Baseline acquisition before contrast administration 1
• Primary utility: Identifies high-attenuation material, atherosclerotic calcifications, intramural hemorrhage, and serves as baseline for assessing enhancement 2, 1
• Modern alternative: Virtual noncontrast series on multienergy CT scanners can replace this phase, reducing radiation exposure 1
• Critical limitation: Noncontrast CT alone has significantly lower sensitivity for detecting visceral organ and vascular injuries and should not be used as the sole imaging method 2, 1

Late Arterial Phase

• Timing: 35 seconds post-injection (optimal range 30-40 seconds) 1, 3, 4
• Vascular opacification: Provides peak arterial enhancement with aortic attenuation of 321-327 HU and superior mesenteric artery enhancement of 304-307 HU 3
• Hypervascular lesion detection: Critical for identifying hypervascular hepatocellular carcinomas, with sensitivity of 73% at 30 seconds compared to only 37% at 20 seconds and 49% at 40 seconds 4
• Hemorrhage detection: Essential for detecting contrast extravasation in acute GI bleeding (85-90% sensitivity, 92% specificity) and trauma 1
• Arterial assessment: Mandatory for evaluating mesenteric ischemia, as arterial phase influences care in 19% of patients compared to portal venous phase alone 2

Portal Venous Phase

• Timing: 60-70 seconds post-injection 1
• Optimal organ enhancement: Provides best bowel wall enhancement and solid organ visualization 2, 1
• Hypovascular lesion detection: Most sensitive phase for hypovascular metastases with 85-91.5% sensitivity 1
• Trauma imaging: Primary phase for solid organ injury detection, though dual-phase imaging including arterial significantly improves accuracy for splenic vascular injury 1
• Venous assessment: Allows evaluation of mesenteric veins and portal vein thrombosis 2

Delayed Phase

• Timing: 90+ seconds post-injection 1
• Urinary tract evaluation: Essential for detecting urinary extravasation in genitourinary trauma, typically performed at 5 minutes (excretory phase) 2
• Lesion characterization: Improves characterization of liver lesions and enhances detection of slow venous bleeding 1
• Selective use: Should be added selectively based on clinical suspicion rather than routinely 2

Protocol Selection by Clinical Indication

Suspected GI Bleeding

• Required phases: Noncontrast, late arterial, and portal venous 1
• Rationale: Multiphase acquisition confirms contrast extravasation and localizes bleeding source 1
• Critical caveat: Avoid oral contrast as it delays scanning and obscures active bleeding 1

Liver Lesion Characterization

• Required phases: Arterial, portal venous, and delayed 1
• Rationale: Hypervascular lesions require arterial phase (peak pancreatic parenchymal enhancement at 15-20 seconds), while hypovascular metastases are best detected on portal venous phase 1, 3
• Hepatobiliary agents: For MRI, gadoxetate provides additional hepatobiliary phase at 20 minutes for improved lesion detection 2

Mesenteric Ischemia

• Required phases: Both arterial and portal venous phases mandatory 2
• Rationale: Arterial phase assesses arterial stenosis, embolism, and thrombosis; portal venous phase evaluates mesenteric veins and bowel wall enhancement 2
• Noncontrast consideration: May be helpful but several studies show it is not required for accurate diagnosis 2

Trauma Evaluation

• Primary phase: Portal venous phase (arterial 20-30 seconds, venous 70-80 seconds) 2
• Enhanced protocol: Addition of 5-minute delayed phase selectively when urogenital injury suspected 2
• High-risk features: Contrast blush, perirenal hematoma >3.5 cm, and medial laceration with urinary extravasation predict nonoperative management failure 2

Pancreatic Imaging

• Optimal timing: Pancreatic parenchymal phase at 40-70 seconds provides significantly greater tumor-pancreas contrast (67 HU) compared to hepatic phase at 70-100 seconds (39 HU) 5
• Vascular assessment: Pancreatic phase also provides superior portal venous opacification compared to later hepatic phase 5

Critical Technical Considerations

Contrast Administration

• Injection rate: 4 mL/sec standard for most protocols 3, 4
• Volume: 2 mL/kg up to 150 mL maximum 3
• Concentration: Higher iodine concentration (300-370 mg I/mL) improves enhancement, particularly for hypervascular tumors 3, 6

Oral Contrast Selection

• Positive contrast: Contraindicated in GI bleeding and CT enterography as it obscures mucosal enhancement and active hemorrhage 1
• Neutral contrast: Preferred for small bowel evaluation (900-1,800 mL over 45-60 minutes), allowing visualization of enhancing lesions against hypointense background 1

Image Acquisition

• Slice thickness: 2.5-5 mm recommended, with thinner slices improving lesion detection 1
• 3D reconstruction: Should be performed for vascular evaluation in mesenteric ischemia 2

Common Pitfalls to Avoid

• Single-phase imaging: Relying solely on portal venous phase misses 19% of arterial lesions in mesenteric ischemia and reduces sensitivity for hypervascular liver lesions 2, 4
• Delayed scanning: Oral contrast administration delays image acquisition in acute settings; avoid when time-sensitive diagnosis needed 2
• Inadequate arterial timing: Early arterial phase (20 seconds) detects only 37% of hypervascular HCC compared to 73% at optimal 30-second timing 4
• Routine delayed phase: Should be selective rather than routine to minimize radiation exposure 2, 1
• Renal insufficiency concerns: In suspected acute mesenteric ischemia with GFR <30, benefits of accurate diagnosis outweigh contrast-induced nephropathy risks 2